Optima Medical Innovations Corp. (OMIC)
Feb 21, 2025 - OMIC was delisted (reason: acquired by Deerfield)
20.01
0.00 (0.00%)
Inactive · Last trade price on Feb 20, 2025
Singular Genomics Systems Revenue
Singular Genomics Systems had revenue of $1.14M in the quarter ending September 30, 2021, with 2.49% growth. This brings the company's revenue in the last twelve months to $1.94M, down -72.87% year-over-year. In the year 2020, Singular Genomics Systems had annual revenue of $4.61M, down -14.09%.
Revenue (ttm)
$1.94M
Revenue Growth
-72.87%
P/S Ratio
0.00
Revenue / Employee
$215,773
Employees
255
Market Cap
48.00
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2020 | 4.61M | -756.66K | -14.09% |
| Dec 31, 2019 | 5.37M | 4.64M | 633.40% |
| Dec 31, 2018 | 732.23K | 338.15K | 85.81% |
| Dec 31, 2017 | 394.08K | -86.82K | -18.05% |
| Dec 31, 2016 | 480.90K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionOMIC News
- 9 months ago - Singular Genomics Announces Closing of Acquisition by Deerfield Management - GlobeNewsWire
- 10 months ago - Investors With Losses Are Invited To Join The Schall Law Firm In An Investigation Into Singular Genomics Systems, Inc. For Securities Fraud - Accesswire
- 10 months ago - Investors With Losses Are Invited To Join The Schall Law Firm In An Inquiry Into Singular Genomics Systems, Inc. For Securities Fraud - Accesswire
- 10 months ago - OMIC Investors Have the Opportunity to Join Investigation of Singular Genomics Systems, Inc. with the Schall Law Firm - PRNewsWire
- 10 months ago - Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Singular Genomics Systems, Inc. For Securities Fraud - Accesswire
- 10 months ago - SINGULAR GENOMICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Singular Genomics Systems, Inc. - OMIC - Business Wire
- 11 months ago - Singular Genomics Enters into Agreement to be Acquired by Deerfield for $20.00 in Cash per Share - GlobeNewsWire
- 1 year ago - Singular Genomics Receives Non-Binding Acquisition Proposal from Concentra Biosciences and Tang Capital - GlobeNewsWire